NCT02099045

Brief Summary

Background: It is well known that emergency physicians can conduct ultrasound examinations as a supplement to initial physical examination. No previous studies have been conducted to evaluate the total findings with ultrasound on a broad unselected group of patients in the Emergency Department. Aim: We aim to identify the pathology found in an unselected cohort of patients in a Rural Emergency Department. Secondarily we aim to quantify the changes done in treatment as a result of the ultrasound examination performed bedside in the Emergency Department. Hypothesis: Supplemental ultrasonographical examination will change diagnostics and treatment in 10 % of an unselected cohort of patients in the Emergency Department. Method: We will perform a structured ultrasound examination of 406 patients on an unselected cohort in the emergency department. All patients age 18 years and above presenting in the emergency department will be included in the study. Patients unwilling to give informed consent will be excluded from the study. Patients will be excluded if the ultrasonographic examination cannot be performed within the first two hours after initial contact with the treating physician. The study will be conducted in two substudies. Sub study 1 including all patient legally competent to give informed consent. Sub study 2 including all legally incompetent patients who cannot give informed consent due to acute illness. These patients will be included in the study under the rules of emergency research. After including the patients we will ask the treating physician a series of binary questions regarding diagnosis and treatment plan. Outcome: Primary outcome is the pathology found by ultrasound in the department. Secondary outcome will be the changes in diagnosis or treatment plan. Pathology and changes in diagnosis/treatment will be stratified according to initial complaint, triage level, age and other factors. This has never been done on unselected patients in the Emergency Department. Ethical considerations and adverse effects: Ultrasound transmits high frequency waves into the tissue, which is reflected to the ultrasound probe. The time and magnitude of the returning sound waves are interpreted into picture on the screen. No adverse effects have been reported on the basis of the sound waves transmitted through the tissue. Some patients might experience discomfort due to the sticky sensation from the application of ultrasound gel. Others might experience discomfort from the pressure applied to the probe under the imaging. Adverse effects, which we are not aware of, may exist. However, clinical ultrasound has existed since the 1950'ies and new adverse effects are unlikely. Publication: All results will be published in international peer-review journals. Also in the event of inconclusive results.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
406

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 28, 2014

Completed
4 days until next milestone

Study Start

First participant enrolled

April 1, 2014

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

January 14, 2015

Status Verified

January 1, 2015

Enrollment Period

1.6 years

First QC Date

March 26, 2014

Last Update Submit

January 13, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pathology found by POC ultrasonography

    Cardiac function. Pericardial effusion more than 3 mm. Left ventricular function: Hyper dynamic, Normal, Mildly reduced, Moderately reduced, Severely reduced. Hypertrophic left ventricle: Ventricle wall \> 1,2 cm Right ventricle function: TAPSE: \> 20 mm: 16-20 mm: 13-15 mm: 10-12 mm: \< 10 mm. Right ventricle wall \> 0,8mm Left ventricle \< right ventricle. Aortic sclerosis, Visible mass in lumen, Visible papillary muscle rupture, Pathology to mitral or tricuspid valve, Other findings. Inferior Vena Cava. IVC diameter : \< 10 mm,10 -15mm, 16- 20mm, \> 20mm IVC respiratory variation: collapse, \> 50%, \<50%, none Lung ultrasound: Absence of lung sliding, Visible pleural effusion, Multiple b-lines (≥3 in focal area) Abdominal ultrasound: Free fluid, Hydronephrosis: Left; Right, Gallbladder wall thickening \> 4 mm Gallbladder width: \> 4 cm,Murphey's sign, Visible cholecystolithiasis, Aortic aneurism: Size in cm Bladder size in ml Evaluation of the deep veins on the lower extremity for DVT

    Within two hours after initial evaluation of the patient.

Secondary Outcomes (1)

  • Changes in diagnostics or treatments plan

    Within 2 hours after primary evaluation of the patient after the ultrasound examination has been performed.

Study Arms (1)

Ultrasound examination

All patients over the age of 18 presenting in the emergency department.

Device: Point of Care Ultrasonography

Interventions

Ultrasound examination

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Unselected consecutive patients in the Emergency Department.

You may qualify if:

  • All patients over the age of 18 presenting at the ED

You may not qualify if:

  • Sonographic examination cannot be performed within the first two hours
  • Failure to consent.
  • Sonographical examination interferes with lifesaving treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emergency Department, Regional Hospital Herning

Herning, 7400, Denmark

RECRUITING

Related Links

Study Officials

  • Jesper Bo Weile, MD

    Research Center for Emergency Medicine

    PRINCIPAL INVESTIGATOR
  • Hans Kirkegaard, MD, Professor, dr.med, ph.d.

    Research Center for Emergency Medicine

    STUDY CHAIR
  • Erik Sloth, MD, professor, dr.med., ph.d

    Department of Anaesthesiology, Skejby University Hospital

    STUDY CHAIR
  • Christian Alcaraz Frederiksen, MD, PhD

    Department of Cardiology, Aarhus University Hospital

    STUDY CHAIR
  • Christian Laursen, MD

    Department of Respiratory Medicine, Odense University Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD student

Study Record Dates

First Submitted

March 26, 2014

First Posted

March 28, 2014

Study Start

April 1, 2014

Primary Completion

November 1, 2015

Study Completion

January 1, 2017

Last Updated

January 14, 2015

Record last verified: 2015-01

Locations